Erick Lucera
Board Member
Bone Biologics Corp (BBLG)Chief Accounting Officer
Dyne Therapeutics, Inc. (DYN)Board Member
SAB Biotherapeutics, Inc. (SABS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-03-31–present
-
Current
2023-01-01–present
-
Current
-
Current
-
Start not stated–2025-03-28
-
Start not stated–2023-12-27
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Dyne Therapeutics, Inc. (DYN) | Chief Financial Officer | $391,970 | $2,695,986 |
| 2024 | Editas Medicine, Inc. (EDIT) | Former Executive Vice President and Chief Financial Officer | $482,600 | $1,809,321 |
| 2023 | Editas Medicine, Inc. (EDIT) | Former Executive Vice President and Chief Financial Officer | $285,615 | $2,215,616 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.